Clinique Neuro-Outaouais Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2013
NCT02146534
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now